FIELD: medicine.
SUBSTANCE: invention relates to the application of a solid medicinal product, which is heated under the impact of an alternating magnetic field, for further therapeutic treatment after surgical ablation of tumours and cancerous ulcers. The medicinal product represents a surgical implant, presented in the form of a physiologically acceptable fabric, sponge or film. The medicinal product contains magnetic particles, which generate heat when excited by an impact of the alternating magnetic field, and in this way, heat the medicinal product.
EFFECT: invention ensures considerable improvement of further treatment after operation on cancerous tumour in comparison with chemotherapy.
21 cl, 14 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF PREVENTION AND/OR TREATMENT OF CANCEROUS DISEASES | 2006 |
|
RU2480201C2 |
| MAGNETIC NANOPARTICLE FOR TREATING AND/OR PREVENTING CANCER, BASED INFUSION SOLUTION AND PHARMACEUTICAL COMPOSITION | 2006 |
|
RU2490027C9 |
| MAGNETIC CONVERTERS REVIEW | 2009 |
|
RU2500622C2 |
| THERAPEUTIC POLYMERIC NANOPARTICLES AND METHODS OF MAKING AND USING SAME | 2014 |
|
RU2682332C2 |
| PLATINUM NANOCOMPOUNDS AND METHODS OF APPLYING THEREOF | 2010 |
|
RU2538199C2 |
| PHARMACEUTICAL DOSED FORM FOR PERORAL INTRODUCTION OF BCL-2 FAMILY INHIBITOR | 2010 |
|
RU2568599C2 |
| TREATING CANCER AND TUMOUR, STIMULATED BY RELEASE OF HEAT GENERATED BY DIFFERENT CHAINS OF MAGNETOSOMES RECOVERED FROM MAGNETO-TACTICAL BACTERIA AND SUBJECTED TO ACTION OF ALTERNATING MAGNETIC FIELD | 2010 |
|
RU2593331C2 |
| TARGETED CONJUGATES AND PARTICLES AND COMPOSITIONS THEREOF | 2015 |
|
RU2695220C2 |
| POLYMER CONTAINING MEDICINAL AGENT BASED ON ANTITUMOR AGENT ETOPOSIDE | 2015 |
|
RU2595859C1 |
| DOSAGE FORMS OF HISTONE DEACETYLASE INHIBITOR IN COMBINATION WITH BENDAMUSTINE AND THEIR APPLICATION | 2011 |
|
RU2609833C2 |
